Steven P. Tanis,Scott D. Larsen,Gerald D. Artman, III,Timothy Parker
申请号:
US14906686
公开号:
US09562012B2
申请日:
2014.07.21
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease, or Huntington's disease), or any combination thereof. Moreover, the present invention also provides methods of treatment for these diseases or disorders.